SABS · SAB Biotherapeutics, Inc. · Exempt Offerings
Market Cap
$310.26M
Shares
90.99M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1833214
CUSIP
78397T202
13F (30d)
55 filings
55 filers
Visit website
Investor relations